Category Archives: Castration Resistant Prostate Cancer

PSMA-directed EndoRadiotherapy of Castration-resISTant prostate cancer (PERCIST). A phase II clinical trial.

Posted on April 21, 2017 by "Coach" Israel Barken M.D.

Theranostics for Castration Resistance Metastatic Prostate Cancer

Posted in Castration Resistant Prostate Cancer, Theranostics, Treatments for Prostate Cancer | Tagged | Leave a comment

Cryoablation Immuno Therapy

Posted on June 9, 2015 by "Coach" Israel Barken M.D.

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease. Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- … Continue reading →

Posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine | Leave a comment

Phase III Prostvac Clinical Study

Posted on December 18, 2014 by "Coach" Israel Barken M.D.

Immune Therapy is an important tool for advanced prostate cancer disease, especially in older patients for whom chemotherapy is excluded because of other serious medical problems. Dr. Barken presents the Prostvac Clinical Study Phase III with a video clip featuring … Continue reading →

Posted in Active Surveillance, Ask Dr. Barken, Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Metastatic Disease, Prostate Cancer, PSA | Leave a comment

Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery.

Posted on January 27, 2014 by "Coach" Israel Barken M.D.

Predictors for response to intermittent androgen    deprivation (IAD) in prostate cancer cases with biochemical progression after surgery. Authors Sciarra A, et al. -Urol Oncol. 2013 Jul;31(5):607-14. Abstract presented and comments included by Dr. Israel Barken, the medical director of the … Continue reading →

Posted in Castration Resistant Prostate Cancer, Intermittent Hormonal Blockade, Prognosis, Radical Prostatectomy, Treatments for Prostate Cancer | Tagged | Leave a comment

Guidelines for Castration Resistant Prostate Cancer

Posted on August 20, 2013 by "Coach" Israel Barken M.D.

This video includes list of new medications approved by FDA and other medications under study for Castration Resistant Prostate Cancer. The guidelines were published by the American Urological Association 2013

Posted in Castration Resistant Prostate Cancer | Leave a comment

Treatment options post Taxotere

Posted on December 16, 2012 by "Coach" Israel Barken M.D.

Question of the week:  What’s available after Taxotere for a patient with bone metastatic disease? Dr. Barken talks to a caller about his options for treatment after chemotherapy. For the Ask Dr Barken Call In Show on Tuesday, Dec. 18th at 6pm … Continue reading →

Posted in Castration Resistant Prostate Cancer, Coaching, Metastatic Disease, Treatments for Prostate Cancer | Leave a comment

MDV 3100 Clinical Study

Posted on April 24, 2012 by "Coach" Israel Barken M.D.

Question of the week: What’s the latest on the MDV 3100 clinical study?  What is the mode of action of this oral drug?   Video Blog Presentation: Dr. Celestia Higano will talk about the status of the drug and info about … Continue reading →

Posted in Castration Resistant Prostate Cancer, Hormonal Blockade, Hormone Refractory Disease, Metastatic Disease, Treatments for Prostate Cancer | Tagged | Leave a comment

New Treatments For Castration Resistant Prostate Cancer

Posted on April 1, 2012 by "Coach" Israel Barken M.D.

For the Ask Dr Barken Call In Show on Tuesday, April 3rd at 6pm Pacific Time:  Dial 1-877-727-3301 to hear the program. Question of the week:    For castration resistant prostate cancer, is it better to do Provenge first or … Continue reading →

Posted in Castration Resistant Prostate Cancer, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer | Tagged , , , | Leave a comment

What is Prolactin and why is it important?

Posted on March 20, 2012 by "Coach" Israel Barken M.D.

Question of the week:   What is Prolactin and why is it important?    The article of the week: Prolactin in men’s health and disease.  Alexander Bolyakov; Current Opinion in Urology 2011, 21:527–534   Dr. Barken answers the questions and presents a … Continue reading →

Posted in Castration Resistant Prostate Cancer, Checklist, Coaching, Hormonal Blockade, Journal Club, Markers, Metastatic Disease, Sexual Dysfunction, Survival prostate cancer, Testosterone, Treatments for Prostate Cancer | Tagged , | Leave a comment

Radium-223 ( Alpharadin): A novel Radiopharmaceutical that Prolongs Survival in Bone Metastatic Disease

Posted on March 13, 2012 by "Coach" Israel Barken M.D.

  The following question is for the Ask Dr Barken Call In Show on Tuesday, March 13th at 6pm Pacific Time.  Dial 1-877-727-3301 to hear the program. Where can I get Alpharadin? What criteria will I need to meet to get … Continue reading →

Posted in Ask Dr. Barken, Bone Metastases, Castration Resistant Prostate Cancer, Metastatic Disease, Metastatic Prostate Cancer Disease, Prostate Cancer, Radiation treatment, Survival prostate cancer, Treatments for Prostate Cancer | Tagged , | Leave a comment